People diagnosed with immune thrombotic thrombocytopenic purpura (TTP) in the U.S. report significant unmet healthcare needs, particularly related to mental health support and relapse…
Takeda’s investigational therapy mezagitamab increased platelet counts in adults with persistent or chronic primary immune thrombocytopenia (ITP) in a Phase 2 trial, with responses seen within days of treatment and the strongest results at the highest dose tested, 600 mg. “This is a novel therapy that works…
Latest news & perspectives
Rare and chronic diseases aren’t always visible. Sometimes, it can be hard for friends and family to understand that you’re very sick if you’re not…
A woman with an extremely rare combination of three autoimmune diseases — immune thrombocytopenia (ITP), autoimmune hemolytic anemia (AIHA), and antiphospholipid syndrome — has been…
